½ÃÀ庸°í¼­
»óǰÄÚµå
1462631

¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå Àü¸Á(-2030³â) : Á¦Ç° À¯Çüº°, ¿¬·É´ëº°, ÃÖÁ¾ »ç¿ëÀÚº° ¹× Áö¿ªº° ºÐ¼®

Stool Management System Market Forecasts to 2030 - Global Analysis By Product (Stoma Bags, Transanal Irrigation Systems and Other Products), Type (Stool Collection Systems and Stool Management Software), Age Group, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ¹è¼³¹° °ü¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2023³â 4¾ï 6,167¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 5.40%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 6¾ï 6,714¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹è¼³¹° °ü¸® ½Ã½ºÅÛÀº ÀÇÀÚ ¹× Á¼® ¹èÄ¡¸¦ °ü¸®ÇÏ´Â ´Ù¾çÇÑ Ãø¸éÀ» °£¼ÒÈ­Çϰí ÀÚµ¿È­Çϱâ À§ÇØ ¼³°èµÈ ¼ÒÇÁÆ®¿þ¾î ¿ëµµÀÔ´Ï´Ù. ÁÖ·Î ±³À° ±â°ü, Çà»çÀå ¹× Á÷Àå¿¡¼­ »ç¿ëµÇ´Â ÀÌ ½Ã½ºÅÛÀº °ü¸®ÀÚ°¡ Á¼®À» È¿À²ÀûÀ¸·Î ÇÒ´çÇϰí, °¡µ¿·üÀ» ¸ð´ÏÅ͸µÇϰí, °¡¿ë¼ºÀ» ÃßÀûÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. Á¾Á¾ Á¼® ¿¹¾à, ½Ç½Ã°£ °¡µ¿·ü ¾÷µ¥ÀÌÆ®, ´õ ³ªÀº ¸®¼Ò½º Ȱ¿ëÀ» À§ÇÑ º¸°í ±â´É µîÀÇ ±â´ÉÀ» Æ÷ÇÔÇÕ´Ï´Ù.

NCBIÀÇ ±â»ç¿¡ µû¸£¸é, 2023³â Àεµ¿¡¼­ 153,020¸íÀÌ ´ëÀå¾Ï Áø´ÜÀ» ¹ÞÀ» °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

Àα¸ÀÇ °í·ÉÈ­

°í·ÉÈ­´Â ³ëÀεéÀÇ º¯½Ç±Ý, º¯ºñ µîÀÇ Áúȯ ¹ß»ý·üÀÌ ³ô¾ÆÁö¸é¼­ °í·ÉÈ­°¡ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ³ªÀ̰¡ µé¸é °Åµ¿ÀÌ ºÒÆíÇϰí Àå ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¸¸¼ºÀûÀÎ °Ç°­ »óÅ¿¡ ºüÁö±â ½±´Ù. ¹è¼³¹° °ü¸® ½Ã½ºÅÛÀº ÀÌ·¯ÇÑ ¹®Á¦¸¦ °ü¸®ÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ³ëÀε鿡°Ô Æí¾ÈÇÔ°ú Á¸¾ö¼ºÀ» Á¦°øÇÏ´Â µ¿½Ã¿¡ °£º´ÀÎÀÇ ºÎ´ãÀ» ´ú¾îÁÝ´Ï´Ù. Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡´Â ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃŰ°í ´Ù¾çÇÑ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ ½ÃÀåÀÇ Çõ½Å°ú ¹ßÀüÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, Á¦Á¶¾÷üµéÀº ³ëÀÎ Àα¸ÀÇ °íÀ¯ÇÑ ¿ä±¸ »çÇ×À» ÃæÁ·½Ã۱â À§ÇØ º¸´Ù È¿À²ÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ¹èº¯ °ü¸® ¼Ö·ç¼ÇÀ» °³¹ßÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

ȯÀÚÀÇ Æí¾ÈÇÔ ¹× ¼ö¿ë¼º

ȯÀÚ Ä¡·á ¿µ¿ª¿¡¼­´Â Æí¾ÈÇÔ°ú ¼ö¿ë¼ºÀÌ ¹è¼³¹° °ü¸® ½Ã½ºÅÛ Ã¤Åÿ¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ȯÀÚÀÇ º¯½Ç±Ý, º¯ºñ µîÀÇ ¹®Á¦¸¦ ÇØ°áÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. Æí¾ÈÇÔÀº ȯÀÚ°¡ °úµµÇÑ ºÒÆíÇÔÀ̳ª °íÅë ¾øÀÌ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¹Ý¸é, ¼ö¿ë¼ºÀº ȯÀÚ°¡ ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» »ç¿ëÇÏ·Á´Â ÀÇÁö¿Í °ü·ÃÀÌ ÀÖÀ¸¸ç Á¾Á¾ »ç¿ë ÆíÀǼº, ½ÅÁßÇÔ, È¿°ú µîÀÇ ¿äÀο¡ ¿µÇâÀ»¹Þ½À´Ï´Ù. ¼º°øÀûÀÎ ¹è¼³¹° °ü¸® ½Ã½ºÅÛÀº Æí¾ÈÇÔ°ú ¼ö¿ë¼ºÀ» ¿ì¼±½ÃÇϰí Çõ½ÅÀûÀÎ µðÀÚÀΰú ¼ÒÀ縦 »ç¿ëÇÏ¿© ȯÀÚ °æÇèÀ» °³¼±Çϰí Ä¡·á ¿ä¹ý Áؼö¸¦ ÃËÁøÇÕ´Ï´Ù.

ȨÄÉ¾î ¼Ö·ç¼Ç

ÀçÅà ÄÉ¾î ¼Ö·ç¼Ç

ȨÄɾî¼Ö·ç¼ÇÁî´Â °í·ÉÈ­¿Í ¿ä½Ç±Ý, Àå Áúȯ µîÀÇ À¯º´·ü Áõ°¡¸¦ ¹è°æÀ¸·Î ±Þ¼ºÀåÇϰí ÀÖ´Â ¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡ ÀÚº»À» ÅõÀÚÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ È¸»çÀÇ Çõ½ÅÀûÀÎ Á¢±Ù ¹æ½ÄÀº Áý¿¡¼­ È¿À²ÀûÀÌ°í ´«¿¡ ¶çÁö ¾Ê°Ô ¹èº¯À» °ü¸®ÇØ¾ß ÇÏ´Â °³Àο¡°Ô Á¾ÇÕÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ȨÄÉ¾î ¼Ö·ç¼ÇÀº ÷´Ü ±â¼ú°ú »ç¿ëÇϱ⠽¬¿î µðÀÚÀÎÀ» ÅëÇÕÇÔÀ¸·Î½á ½ÃÀåÀÇ Å« °ÝÂ÷¸¦ ÇØ¼ÒÇϰí ȯÀÚ¿¡°Ô Æí¸®ÇÔ°ú Á¸¾ö¼ºÀ» Á¦°øÇÔ°ú µ¿½Ã¿¡ °£º´ÀÎÀÇ ºÎ´ãÀ» ´ú¾îÁÙ ¼ö ÀÖ½À´Ï´Ù. Á¢±Ù¼º°ú °æÁ¦¼º¿¡ ÁßÁ¡À» µÐ ÀÌ È¸»çÀÇ ½Ã½ºÅÛÀº ÀçÅà ¹èº¯ °ü¸®¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ¼ºÀå°ú ½ÃÀå ħÅõ¸¦ À§ÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

±â¼úÀÇ ÁøºÎÈ­

±â¼úÀÇ ÁøºÎÈ­´Â ±â¼ú ¹ßÀüÀÇ ºü¸¥ ¼Óµµ·Î ÀÎÇØ ½É°¢ÇÑ À§ÇùÀÌ µÇ°í ÀÖ½À´Ï´Ù. »õ·Î¿î ±â¼ú Çõ½ÅÀÌ µîÀåÇÔ¿¡ µû¶ó ¿À·¡µÈ ½Ã½ºÅÛÀº ±¸½ÄÀÌ µÇ¾î È¿°ú°¡ ¾ø¾îÁ® ¼ö¿ä °¨¼Ò·Î À̾îÁú À§ÇèÀÌ ÀÖ½À´Ï´Ù. Á¦Á¶¾÷ü´Â ÁøÈ­ÇÏ´Â ±â¼ú°ú ¼ÒºñÀÚÀÇ ±â´ë¿¡ ºÎÀÀÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ Áö¼ÓÀûÀ¸·Î ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ ±¸½Ä ½Ã½ºÅÛ°ú »õ·Î¿î ÀÇ·á ÀÎÇÁ¶ó °£ÀÇ È£È¯¼º ¹®Á¦°¡ ¹ß»ýÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ±¸½Ä Á¦Ç°ÀÇ ¸Å·ÂÀ» ´õ¿í ¶³¾î¶ß¸± ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ :

Äڷγª19 ÆÒµ¥¹ÍÀº ¿©·¯ Ãø¸é¿¡¼­ ¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ ¾ÐµµµÇ°í ¹ÙÀÌ·¯½º °ü¸®¿¡ ÀÚ¿øÀÌ ÁýÁߵǸ鼭, À§Àå ¹®Á¦¿Í °ü·ÃµÈ ÀÇ·á ÀýÂ÷¸¦ Æ÷ÇÔÇÑ ºñÇʼöÀûÀÎ ÀÇ·á ÀýÂ÷°¡ ´À·ÁÁö°í ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÇ·á ȯ°æ¿¡¼­ Àå Á¶Àý¿¡ ¹®Á¦°¡ Àִ ȯÀÚµéÀ» À§ÇØ ÀÚÁÖ »ç¿ëµÇ´Â ¹è¼³¹° °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ °¨¼ÒÇßÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °ø±Þ¸ÁÀÇ È¥¶õ°ú ¹°·ù ¹®Á¦°¡ ÀÇ·á±â±âÀÇ »ý»ê°ú À¯Åë¿¡ ¿µÇâÀ» ¹ÌÃÄ ¹è¼³¹° °ü¸® ½Ã½ºÅÛÀÇ ºÎÁ·°ú °ø±Þ Áö¿¬À¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °æÇ×¹® °ü·ù ½Ã½ºÅÛ ºÐ¾ß°¡ °¡Àå Å« ½ÃÀåÀ» Çü¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°æÇ×¹® °ü·ù ½Ã½ºÅÛ ºÐ¾ßÀÇ ¼ºÀåÀº Àå ±â´É Àå¾Ö ¹× º¯½Ç±Ý °ü¸®¿¡ ÀÖ¾î °æÇ×¹® °ü·ùÀÇ ÀÌÁ¡¿¡ ´ëÇÑ È¯ÀÚ¿Í ÀÇ·á Àü¹®°¡µé »çÀÌ¿¡¼­ ÀνÄÀÌ ³ô¾ÆÁø µ¥ ±âÀÎÇÕ´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î º¸´Ù »ç¿ëÇϱ⠽±°í È¿°úÀûÀÎ °ü·ù ½Ã½ºÅÛÀÌ °³¹ßµÇ¾î ȯÀÚÀÇ Æí¾ÈÇÔ°ú ¼øÀÀµµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í·ÉÈ­ Àα¸ Áõ°¡¿Í ½Å°æ Àå¾Ö ¹× ô¼ö ¼Õ»ó Áõ°¡·Î ÀÎÇØ ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ ÀáÀçÀûÀΠȯÀÚÃþÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â º´¿ø ºÐ¾ßÀÔ´Ï´Ù.

¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ º´¿ø ºÎ¹®Àº È¿°úÀûÀÎ ¹èº¯ °ü¸®°¡ ÇÊ¿äÇÑ ¼ÒÈ­±â Áúȯ ¹× Áúº´ÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Å« ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. º´¿øÀº ȯÀÚ °ü¸® ¹× À§»ý ±âÁØÀ» °³¼±Çϱâ À§ÇØ Áö¼ÓÀûÀ¸·Î ³ë·ÂÇϰí ÀÖÀ¸¸ç, °¨¿° ¹× ÇÕº´Áõ ¿¹¹æÀ» À§ÇØ ¹è¼³¹° °ü¸® ½Ã½ºÅÛÀ» äÅÃÇÏ´Â ºñÀ²ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á ±â¼úÀÇ ¹ßÀüÀ¸·Î º¸´Ù È¿À²ÀûÀ̰í ȯÀÚ Ä£È­ÀûÀÎ ¹è¼³¹° °ü¸® ½Ã½ºÅÛÀÌ °³¹ßµÇ¾î ÀÇ·á ½Ã¼³¿¡ ´õ¿í ¸Å·ÂÀûÀ¸·Î ´Ù°¡°¥ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª :

ºÏ¹Ì´Â ¿°Áõ¼º Àå Áúȯ ¹× ´ëÀå¾Ï°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ È¿°úÀûÀÎ ¹èº¯ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ³ôÀº ¼öÁØÀÇ ÀÇ·á ÀÎÇÁ¶ó¿Í À¯¸®ÇÑ »óȯ Á¤Ã¥À¸·Î ÀÎÇØ ÀÇ·á ½Ã¼³¿¡¼­ ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿åâ ¹× °¨¿°°ú °°Àº ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â ¹è¼³¹° °ü¸® ½Ã½ºÅÛÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ·áÁøÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¹è¼³¹° °ü¸® ½Ã½ºÅÛÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼ú ¹ßÀü°ú Á¦Ç° Çõ½ÅÀº ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üÀÇ ´Ù¾çÇÑ ¿ä±¸¸¦ ÃæÁ·½ÃŰ¸ç ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄɾ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °í·ÉÈ­°¡ ÁøÇàµÇ¸é¼­ ¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áß±¹, Àεµ, ÀϺ» µîÀÇ ±¹°¡¿¡¼­ ÀÇ·á ±â¼úÀÇ ¹ßÀü°ú ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±ÀÌ °áÇÕµÇ¾î ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¯½Ç±Ý ¹× ±âŸ Àå °ü·Ã ¹®Á¦¸¦ °ü¸®Çϱâ À§ÇÑ Çõ½ÅÀûÀÎ Á¦Ç° ¹× ½Ã¼úÀÇ Ã¤ÅÃÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(ÃÖ´ë 3°³»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤Ä¡, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ÀÚ·á
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå PorterÀÇ Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • Àå·ç¹é
    • ȸÀå Àå·ç¹é
    • ÀΰøÇ×¹® ¹é
    • ¿ä·Î Àå·ç¹é
  • °æÇ×¹®Àû¼¼Àå½Ã½ºÅÛ
    • Á÷Àå Ä«Å×ÅÍ
    • dz¼± Ä«Å×ÅÍ Àåºñ
    • ħ´ë ½Ã½ºÅÛ
    • ÄÜ µð¹ÙÀ̽º
    • ¹Ì´Ï µð¹ÙÀ̽º
    • ¾Ö³Î Ç÷¯±×
    • ±âŸ °æÇ×¹® ¼¼Àå ½Ã½ºÅÛ
  • ±âŸ Á¦Ç°

Á¦6Àå ¼¼°èÀÇ ¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå : À¯Çüº°

  • ¹èº¯ ȸ¼ö ½Ã½ºÅÛ
  • ¹èº¯ °ü¸® ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå ¼¼°èÀÇ ¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå : ¿¬·ÉÃþº°

  • ¼Ò¾Æ
  • ¼ºÀÎ

Á¦8Àå ¼¼°èÀÇ ¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Àå±âÄɾÅÍ
  • º´¿ø
  • ȨÄɾî ȯ°æ
  • Ŭ¸®´Ð
  • Áø´Ü¼¾ÅÍ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ¼¼°èÀÇ ¹è¼³¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à/ÆÄÆ®³Ê½Ê/Çù¾÷/ÇÕÀÛÅõÀÚ(JV)
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • B. Braun Medical Ltd
  • CliniMed Limited
  • Coloplast Corp
  • Consure Medical
  • ConvaTec Inc
  • Dentsply Sirona Company
  • Hollister Incorporated
  • Nu-Hope Laboratories
  • Primed Halberstadt Medizintechnik GmbH
  • ProSys International Ltd
  • Qufora
LSH 24.05.10

According to Stratistics MRC, the Global Stool Management System Market is accounted for $461.67 million in 2023 and is expected to reach $667.14 million by 2030 growing at a CAGR of 5.40% during the forecast period. A stool management system is a software application designed to streamline and automate various aspects of managing stools or seating arrangements. Primarily used in educational institutions, event venues, and workplaces, this system helps administrators efficiently assign seats, monitor occupancy, and track availability. It often includes features such as seat reservations, real-time occupancy updates, and reporting functionalities for better resource utilization.

According to an NCBI article, it is estimated that in 2023, 153,020 people will be diagnosed with colorectal cancer in India.

Market Dynamics:

Driver:

Aging population

The aging population is a significant driver due to the higher incidence of conditions such as fecal incontinence and constipation among the elderly. As people age, they are more prone to mobility issues and chronic health conditions that affect bowel function. Stool management systems offer a solution for managing these issues, providing comfort and dignity to seniors while reducing the burden on caregivers. The growing elderly population worldwide amplifies the demand for such systems, prompting innovations and advancements in the market to cater to diverse needs. Consequently, manufacturers are focusing on developing more efficient and user-friendly stool management solutions to address the specific requirements of the aging demographic.

Restraint:

Patient comfort and acceptance

In the realm of patient care, comfort and acceptance are pivotal factors in the adoption of stool management systems. These systems aim to address issues such as fecal incontinence or constipation in patients. Comfort is crucial, as it ensures that patients can undergo treatment without undue discomfort or distress. Acceptance, on the other hand, relates to the willingness of patients to use these systems, often influenced by factors like ease of use, discretion, and effectiveness. Successful stool management systems prioritize both comfort and acceptance, employing innovative designs and materials to enhance the patient experience and promote adherence to treatment regimens.

Opportunity:

Homecare solutions

Homecare Solutions is poised to capitalize on the burgeoning stool management system market, driven by an aging population and an increasing prevalence of conditions like incontinence and bowel disorders. Their innovative approach offers a comprehensive solution for individuals requiring efficient and discreet stool management at home. By integrating advanced technology and user-friendly design, Homecare Solutions addresses a significant gap in the market, providing convenience and dignity to patients while easing the burden on caregivers. With a focus on accessibility and affordability, their system promises to revolutionize home-based stool management, presenting a lucrative opportunity for growth and market penetration.

Threat:

Technological obsolescence

Technological obsolescence poses a significant threat due to the rapid pace of technological advancements. As new innovations emerge, older systems risk becoming outdated and ineffective, leading to a decline in demand. Manufacturers must continually invest in research and development to keep pace with evolving technologies and consumer expectations. Additionally, compatibility issues may arise between older systems and newer healthcare infrastructure, further diminishing the appeal of outdated products.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the stool management system market in several ways. With healthcare systems overwhelmed and resources diverted towards managing the virus, there has been a slowdown in non-essential medical procedures, including those related to gastrointestinal issues. Consequently, the demand for stool management systems, which are often utilized in healthcare settings for patients with bowel control problems, may have experienced a decline. Additionally, supply chain disruptions and logistical challenges have affected the production and distribution of medical devices, potentially leading to shortages or delays in acquiring stool management systems.

The transanal irrigation systems segment is expected to be the largest during the forecast period

The growth in the transanal irrigation systems segment can be attributed to increased awareness among patients and healthcare professionals about the benefits of transanal irrigation in managing bowel dysfunction and fecal incontinence. Advancements in technology have led to the development of more user-friendly and effective irrigation systems, enhancing patient comfort and compliance. Additionally, a growing aging population, along with rising incidences of neurological disorders and spinal cord injuries, has expanded the potential patient pool for such systems.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospital segment of the stool management system market has experienced significant growth due to an increasing prevalence of gastrointestinal disorders and diseases, which necessitates effective management of stool. Hospitals are constantly striving to improve patient care and hygiene standards, leading to a higher adoption rate of stool management systems to prevent infections and complications. Advancements in medical technology have led to the development of more efficient and patient-friendly stool management systems, making them more attractive to healthcare facilities.

Region with largest share:

The North American region has experienced significant growth due to an increasing prevalence of chronic diseases such as inflammatory bowel disease and colorectal cancer in the region, driving the demand for effective stool management solutions. The region boasts advanced healthcare infrastructure and favourable reimbursement policies, facilitating greater adoption of these systems in healthcare facilities. Moreover, rising awareness among healthcare professionals about the benefits of stool management systems in preventing complications like pressure ulcers and infections has fuelled their uptake. Also, technological advancements and product innovations further contribute to market expansion, catering to the diverse needs of patients and healthcare providers.

Region with highest CAGR:

The Asia-Pacific region has experienced substantial growth in the stool management system market due to rising awareness about healthcare and the aging population. Additionally, advancements in medical technology, coupled with improved healthcare infrastructure in countries like China, India, and Japan, have facilitated market expansion. Moreover, the adoption of innovative products and procedures for managing fecal incontinence and other bowel-related issues has further propelled market growth.

Key players in the market

Some of the key players in Stool Management System market include B. Braun Medical Ltd, CliniMed Limited, Coloplast Corp, Consure Medical, ConvaTec Inc, Dentsply Sirona Company, Hollister Incorporated, Nu-Hope Laboratories, Primed Halberstadt Medizintechnik GmbH, ProSys International Ltd. and Qufora.

Key Developments:

In July 2023, Coloplast announced that it will acquire wound care product company Kerecis for $1.3 billion. The acquisition will give Coloplast an opportunity to strategically strengthen its presence in the advanced wound care market by entering the high-growth, U.S.-centric biologics segment.

In May 2023, Convatec announced that it partnered with Beta Bionics on the launch of the iLet Bionic Pancreas for automated insulin delivery. FDA cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software. Convatec offers design and manufacturing services for infusion set technologies and insertion devices for insulin pump treatment. Beta Bionics' iLet uses its inset and contact detach infusion sets for subcutaneous insulin administration.

Products Covered:

  • Stoma Bags
  • Transanal Irrigation Systems
  • Other Products

Types Covered:

  • Stool Collection Systems
  • Stool Management Software

Age Groups Covered:

  • Paediatric
  • Adults

End Users Covered:

  • Ambulatory Surgical Centres
  • Long-Term Care Centres
  • Hospitals
  • Home Care Settings
  • Clinics
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Stool Management System Market, By Product

  • 5.1 Introduction
  • 5.2 Stoma Bags
    • 5.2.1 Ileostomy Bags
    • 5.2.2 Colostomy Bags
    • 5.2.3 Urostomy Bags
  • 5.3 Transanal Irrigation Systems
    • 5.3.1 Rectal Catheters
    • 5.3.2 Balloon Catheter Devices
    • 5.3.3 Bed Systems
    • 5.3.4 Cone Devices
    • 5.3.5 Mini Devices
    • 5.3.6 Anal Plugs
    • 5.3.7 Other Transanal Irrigation Systems
  • 5.4 Other Products

6 Global Stool Management System Market, By Type

  • 6.1 Introduction
  • 6.2 Stool Collection Systems
  • 6.3 Stool Management Software

7 Global Stool Management System Market, By Age Group

  • 7.1 Introduction
  • 7.2 Paediatric
  • 7.3 Adults

8 Global Stool Management System Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centres
  • 8.3 Long-Term Care Centres
  • 8.4 Hospitals
  • 8.5 Home Care Settings
  • 8.6 Clinics
  • 8.7 Diagnostic Centers
  • 8.8 Other End Users

9 Global Stool Management System Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 B. Braun Medical Ltd
  • 11.2 CliniMed Limited
  • 11.3 Coloplast Corp
  • 11.4 Consure Medical
  • 11.5 ConvaTec Inc
  • 11.6 Dentsply Sirona Company
  • 11.7 Hollister Incorporated
  • 11.8 Nu-Hope Laboratories
  • 11.9 Primed Halberstadt Medizintechnik GmbH
  • 11.10 ProSys International Ltd
  • 11.11 Qufora
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦